RTTNews | Sep 29, 2020 07:51AM EDT

07:50 Tuesday, September 29, 2020 (RTTNews.com) - Cepheid, an operating company within Danaher Corp.'s (DHR) Diagnostics platform, has received Emergency Use Authorization from the FDA for Xpert Xpress SARS-CoV-2/Flu/RSV molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single sample. The company expects to begin shipping to US customers the new EUA combination test this week, with expected CE-IVD availability in November.

The four-in-one test is designed for use on any of Cepheid's over 26,000 GeneXpert Systems placed worldwide, with results delivered in approximately 36 minutes.

Read the original article on RTTNews ( https://www.rttnews.com/3132191/cepheid-s-sars-cov-2-flu-rsv-test-receives-emergency-use-authorization.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved